Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)
Condition(s):Coronavirus Disease 2019Last Updated:January 14, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Coronavirus Disease 2019Last Updated:January 14, 2022Unknown status
Condition(s):Endophthalmitis and Orbital CellulitisLast Updated:July 2, 2020Completed
Condition(s):Fibromyalgia; Coronavirus Disease 2019 PandemicLast Updated:January 18, 2023Completed
Condition(s):Coronavirus Disease 2019 COVID-19Last Updated:May 6, 2023Completed
Condition(s):Coronavirus Disease 2019 (COVID-19)Last Updated:April 21, 2022Completed
Condition(s):Coronavirus Disease 2019 (COVID-19)Last Updated:February 1, 2021Completed
Condition(s):Asymptomatic COVID-19 Infection Laboratory-Confirmed; Symptomatic COVID-19 Infection Laboratory-ConfirmedLast Updated:February 20, 2024Active, not recruiting
Condition(s):Cutaneous Manifestations; Skin Manifestations; COVID-19; COVID-19 Pneumonia; COVID-19 Pandemic; Corona Virus Infection; Coronavirus Disease 2019; Sars-CoV-2 InfectionLast Updated:November 22, 2021Completed
Condition(s):COVID-19Last Updated:December 15, 2022Recruiting
Condition(s):Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)Last Updated:May 6, 2023Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.